1. 55P Incidence and clinical implications of late immune-related adverse events in long responders to PD-1/PD-L1 checkpoint inhibitors: A multicenter study. (15th December 2019) Authors: Nigro, O; Cortellini, A; Giusti, R; Marchetti, P; De Galitiis, F; Di Pietro, F R; Bersanelli, M; Lazzarin, A; Galetta, D; Pizzutillo, P; Santini, D; Torniai, M; De Giglio, A; Russo, A; Silva, R R; Bolzacchini, E; Natoli, C; Rijavec, E; Vallini, I; Pinotti, G Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. C48Response rate by molecular subtypes and p53 expression in neoadjuvant therapy for breast cancer with TAC regimen: a single-centre experience. (6th November 2017) Authors: Marcon, I; Vallini, I; Bolzacchini, E; Ritorna, A; Giaquinto, A; Pinotti, G Journal: Annals of oncology Issue: Volume 28(2017)Supplement 6 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Increased total serum IgE concentration in patients who have undergone splenectomy after trauma. Issue 11 (November 1985) Authors: Chelazzi, G; Pinotti, G; Nicora, C; Rossi, D; Senaldi, G Journal: Journal of clinical pathology Issue: Volume 38:Issue 11(1985) Page Start: 1309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. MGMT methylation in diffuse large B-cell lymphoma: validation of quantitative methylation-specific PCR and comparison with MGMT protein expression. Issue 8 (28th July 2009) Authors: Uccella, S; Cerutti, R; Placidi, C; Marchet, S; Carnevali, I; Bernasconi, B; Proserpio, I; Pinotti, G; Tibiletti, M G; Furlan, D; Capella, C Journal: Journal of clinical pathology Issue: Volume 62:Issue 8(2009) Page Start: 715 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗